|
|
Sangamo Therapeutics, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: 2023 EventsI personally think more likely, especially in the wake of this AZ deal, to be indication specific, just like how Biogen and Novartis deals were structured for CNS. |
||||||||||||
|
|
return to message board, top of board |
